Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kentaro Machida, Tomotaka Kawayama, Masaharu Kinoshita, Masakazu Ichinose, Tohru Tsuda, Shohei Takata, Hiroshi Koto, Makoto Yoshida, Yoshinori Ashihara, Masaru Kawashima, Hideaki Suna & Hiromasa Inoue. (2019) Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2175-2184.
Read now
Read now
Umberto Leone Roberti Maggiore, Carolina Scala, Pier Luigi Venturini & Simone Ferrero. (2013)
Imidafenacin for the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 14:10, pages 1383-1397.
Read now
Read now
Articles from other publishers (8)
Seok Cho, Soon-Sun Kwon, Kwang Woo Lee, Tag Keun Yoo, Dong Gil Shin, Soo Woong Kim, Jae Hyun Bae, Hoon Choi & Young Ho Kim. (2017) A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms. International Journal of Clinical Practice 71:5, pages e12938.
Crossref
Crossref
Takanobu Yamazaki, Ayako Fukata & Yukiko Muraki. (2016) Imidafenacin exerts the antidiuretic effect by enhancing vasopressin-related responses in orally water-loaded rats. European Journal of Pharmacology 791, pages 72-77.
Crossref
Crossref
Shiori Kuraoka, Yoshihiko Ito, Hirokazu Wakuda, Kazumasa Shinozuka, Satomi Onoue & Shizuo Yamada. (2016) Characterization of muscarinic receptor binding by the novel radioligand, [3H]imidafenacin, in the bladder and other tissues of rats. Journal of Pharmacological Sciences 131:3, pages 184-189.
Crossref
Crossref
Yanyan Hu, Lu Shen, Liupeng Wang, Tingting Yuan, Yi Sun, Yawen Yuan, Wei Qian & Jin Yang. (2016) A liquid chromatography-tandem mass spectrometry method for the quantitation of imidafenacin in human plasma: application to a clinical pharmacokinetic study. Analytical Methods 8:38, pages 6903-6908.
Crossref
Crossref
SHIGETAKA SUEKANE, KOUSUKE UEDA, SHUNSUKE SUYAMA, TOKUMASA HAYASHI, NORIYUKI TOYOZAWA, MAKI YOSHITAKE, KIYOAKI NISHIHARA, NAO SAKASHITA, NAOHISA UCHIMURA & KEI MATSUOKA. (2015) Comprehensive Health-Related Quality of Life is Influenced by Nocturia and Sleep Disturbance: Investigation Based on the SF-8. The Kurume Medical Journal 62:1.2, pages 9-16.
Crossref
Crossref
Ryuji SAKAKIBARA, Hitoshi HAMANO & Hiromitsu YAGI. (2014) Cognitive Safety and Overall Tolerability of Imidafenacin in Clinical Use: A Long-Term, Open-Label, Post-Marketing Surveillance Study. LUTS: Lower Urinary Tract Symptoms 6:3, pages 138-144.
Crossref
Crossref
C. Park, J. Park, M.-S. Choo, J. C. Kim, J. G. Lee, J. Z. Lee, K.-S. Lee, D. Y. Kim, S.-J. Lee & J. T. Seo. (2014) A randomised, prospective double-blind, propiverine-controlled trial of imidafenacin in patients with overactive bladder. International Journal of Clinical Practice 68:2, pages 188-196.
Crossref
Crossref
Akira Yoshida, Shiori Kuraoka, Yoshihiko Ito, Takashi Okura, Yoshiharu Deguchi, Atsushi Otsuka, Seiichiro Ozono, Masayuki Takeda, Keisuke Masuyama, Isao Araki & Shizuo Yamada. (2014) Muscarinic Receptor Binding of the Novel Radioligand, [3H]Imidafenacin in the Human Bladder and Parotid Gland. Journal of Pharmacological Sciences 124:1, pages 40-46.
Crossref
Crossref